Andrew Huberman· PhD
Given the immense interest in peptides and divergent views about peptides of various types, I assembled a small collection of experts that I’ll be talking to (separately) on the podcast.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Given the immense interest in peptides and divergent views about peptides of various types, I assembled a small collection of experts that I’ll be talking to (separately) on the podcast.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.